Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:46 AM
Ignite Modification Date: 2025-12-26 @ 1:26 AM
NCT ID: NCT01370733
Description: Primarily systematic assessments, some reporting was unsolicited although minimal.
Frequency Threshold: 2
Time Frame: All subject Adverse Events are tracked from the signing of Informed Consent through 4 weeks after the double-blind acute phase has been completed or Early Termination.
Study: NCT01370733
Study Brief: Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Active sTMS Treatment with the NEST-1 Device NEST-1 (NeoSync EEG Synchronized TMS): The NeoSync EEG Synchronized TMS (NEST) is an electromechanical medical device that produces and delivers a sinusoidal magnetic field to areas of the brain in the treatment of Major Depressive Disorder. None None 2 103 80 103 View
Sham Treatment with a sham (inactive) device, identical in sound and appearance to the NEST-1 Device SHAM: The sham device is configured to simulate the actual NEST-1 device without sTMS therapy being actively delivered. None None 1 99 42 99 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Hospitalization (Suicide Attempt) SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (Unspecified) View
Hospitalization (Risk of Self Harm) SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (Unspecified) View
Hospitalization (Dehydration) SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (Unspecified) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Tinnitus SYSTEMATIC_ASSESSMENT Ear and labyrinth disorders MedDRA (Unspecified) View
Visual Disturbance SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Dyschezia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (Unspecified) View
Non-Specific GI Discomfort SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (Unspecified) View
Back Pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (Unspecified) View
Hand/Arm/Shoulder Pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (Unspecified) View
Leg and Foot Pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (Unspecified) View
Agitation SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (Unspecified) View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (Unspecified) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (Unspecified) View
Paresthesia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (Unspecified) View
Insomnia SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (Unspecified) View
Lack of Energy SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (Unspecified) View
Respiratory Infection SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (Unspecified) View